Influence of interleukin-6 on the pharmacokinetics and pharmacodynamics of osimertinib in patients with non-small cell lung cancer.
Saved in:
| Title: | Influence of interleukin-6 on the pharmacokinetics and pharmacodynamics of osimertinib in patients with non-small cell lung cancer. |
|---|---|
| Authors: | Yokota H; Department of Pharmacy, Akita University Hospital, Akita, Japan., Sato K; Department of Internal Medicine Division of Respiratory Medicine, Akita University School of Medicine, Akita, Japan., Sakamoto S; Department of Internal Medicine Division of Respiratory Medicine, Akita University School of Medicine, Akita, Japan., Okuda Y; Department of Internal Medicine Division of Respiratory Medicine, Akita University School of Medicine, Akita, Japan., Takeda M; Department of Internal Medicine Division of Respiratory Medicine, Akita University School of Medicine, Akita, Japan., Akamine Y; Department of Pharmacy, Akita University Hospital, Akita, Japan., Nakayama K; Department of Internal Medicine Division of Respiratory Medicine, Akita University School of Medicine, Akita, Japan., Miura M; Department of Pharmacy, Akita University Hospital, Akita, Japan. m-miura@hos.akita-u.ac.jp.; Department of Pharmacokinetics, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, 010-8543, Japan. m-miura@hos.akita-u.ac.jp. |
| Source: | Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2025 Mar 29; Vol. 95 (1), pp. 49. Date of Electronic Publication: 2025 Mar 29. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
